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 GM crops in Africa: polarising the debate 
 
Ian Scoones, co-director of the ESRC STEPS Centre based at the University of Sussex, 
UK and Dominic Glover of the Technology and Agrarian Development Group at 
Wageningen University in the Netherlands explore the fallout of a new book on 
agricultural biotechnology in Africa. 
 
Just as everyone thought that the debate about genetically-modified (GM) crops had 
been more-or-less been settled around a moderate position which recognises that, while 
they could be useful in some circumstances, they are not the solution to everything, a 
new book bursts onto the scene that once again polarises the debate. ‘ 
 
Starved for Science: How Biotechnology is Being Kept out of Africa’ is a provocative 
polemic from US-based political science professor, Robert Paarlberg1.  It argues that GM 
crops must play the central role in solving Africa’s hunger and poverty and that, through 
inadequate investment, external lobbying and stringent regulations, Africa’s farmers are 
being deprived of the technology and prevented from achieving agricultural success. The 
blame lies primarily with Europe, according to Paarlberg, and especially with European 
NGOs and governments trying to foist their affluent values and precautionary 
sensibilities on Africa’s poor people. 
 
The book has become influential in debates about African science and agriculture 
around the world. Renowned Oxford University development economist Paul Collier, for 
example, heaped praise on the book in an article in the influential journal Foreign Affairs. 
In a UK House of Lords debate, Liberal Democrat peer Dick Taverne described it as 
“one of the most important books I have read in years”. Across the Atlantic, Paarlberg 
was recently invited to testify before the US Senate Committee on Foreign Relations. 
Nina Fedoroff, Science and Technology Adviser to the US Secretary of State and to the 
Administrator of the U.S. Agency for International Development (USAID), repeated the 
book’s arguments in a major policy speech2. This is no fringe publication: it has been 
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published by Harvard University Press, with a foreword by two Nobel laureates, the plant 
breeder Norman Borlaug and former US president Jimmy Carter. It deserves to be taken 
seriously. 
 
Arguments and questions 
 
What are Paarlberg’s arguments? There is much to agree with in the book. Large 
chunks of it are entirely uncontroversial. For instance, Paarlberg is quite correct that 
there has been long-term and systematic underinvestment in African agriculture, 
especially in scientific research and technology development. Few would dispute the 
assertion that investment in agricultural research offers very high returns and is a key 
weapon in the fight against poverty and hunger, and indeed the book draws on 
numerous well-established sources to make the case.3 
 
That such arguments have long been ignored by policymakers and aid programmes is 
also well-recognised. Yet Paarlberg pays too little attention to the substantial new efforts 
that have got under way in recent years.  For example, two serious, strategic initiatives 
for African agriculture, backed by an array of international donors, are the Alliance for a 
Green Revolution in Africa (AGRA) and the African Union’s Comprehensive Africa 
Agriculture Development Programme (CAADP).4 
  
Where many would part company with Paarlberg is his explicit assertion that there is 
only one kind of “science-based agriculture” that is worth investing in. It is a high-tech, 
biotechnology-based science, strongly focused on genetic engineering. Starved for 
Science summarily dismisses a slew of other scientifically-validated approaches to 
agriculture, including low-external input approaches, integrated pest and soil fertility 
management and even other types of biotechnology. This is entirely unjustified. Much 
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solid scientific research demonstrates that such approaches have performed well in 
African contexts – sometimes better than higher-tech, higher-cost technologies.5 
 
Also, the record of African agriculture is by no means all doom-and-gloom. But a 
detailed, disaggregated look at the data reveals numerous successes6. For example, in 
north and west Africa, agricultural production per capita increased by more than 40% 
between 1981–83 and 2003–05, and total output value increased by an amount equal to 
that seen in Asia after the 1960s Green Revolution. Smallholder successes in Africa 
have included hybrid maize production in Zimbabwe and Kenya, cassava and cotton in 
West Africa and improved bananas in Uganda. The fact is all technologies must perform 
within a social, economic, institutional and market context. This is an especially 
challenging requirement in large parts Africa and the main underlying reason for the 
mixed track record of science and technology in African farming. Unfortunately, in 
Paarlberg’s book there is little sense of place or context. The vast and varied continent is 
referred to in a series of sweeping generalisations – as are Africa’s farmers. 
 
Keeping GM out of Africa? 
 
Paarlberg argues that GM crops are being ‘kept out of Africa’ because of the insidious 
influence of mostly European lobby groups, leading to the imposition of “stifling 
regulations” based on “extreme precaution”. The roll-call of the bad guys is long, from 
the prime villains such as Food First, Greenpeace or the International Federation of 
Organic Agriculture Movements to the United Nations and the Ford Foundation. All are 
blamed for preventing what Paarlberg calls a “science-based escape from rural 
poverty”.7 
 
                                               
5
 Pretty J, Noble A D, Bossio D, Dixon J, Hine R E, Penning de Vries F W T and Morison J I L. 
2006. Resource-conserving agriculture increases yields in developing countries, Environmental 
Science & Technology 40(4), 1114 -1119.; UNEP (2009). The Environmental Food Crisis : The 
Environment's Role in Averting Future Food Crisis, Nairobi: UNEP. 
6 Wiggins, S. (2009) Can the smallholder model deliver poverty reduction and food 
security for a rapidly growing population in Africa? Paper presented at the FAO 
conference, How to Feed the World, June 26-29. Rome: FAO ( 
http://www.future-agricultures.org/Documents/Smallholder_S-Wiggins_Jul-09.pdf); Haggblade, S 
(2004). Building on Successes in African Agriculture, 2020 Focus No. 12. Washington DC: IFPRI. 
7
 Paarlberg (2008: xii-xiii). 
There has of course been an intense debate about GM crops in Africa which has drawn 
on arguments from elsewhere, but the idea that this has been the main influence on 
decision-making by national governments in Africa is not substantiated. GM technologies 
have received political backing at the highest levels of African government and policy-
making, and research efforts are underway in countries from Burkina Faso to Malawi8.  
 
At the same time policymakers across Africa have been deluged with information and 
misinformation from all sides. The pro-GM lobby has been every bit as active as the 
environmental NGOs, bombarding decision-makers and media organisations with slick 
marketing materials and whisking officials on free trips to the United States to visit 
Monsanto’s headquarters in St Louis. 
 
Precautionary Europeans are thus not the only ones offering to help African 
governments develop their regulatory regimes; US government-sponsored schemes 
have provided both biosafety training programmes for regulators and model legal 
frameworks for African countries to adopt.9 American and European players have fought 
a fierce tug-of-war over policy, in which African regulators and policymakers have often 
been unwilling bystanders.10 
 
GM crops: the track record 
 
What, then, is the detailed, site-specific evidence from the field on the performance of 
GM technologies? More than ten years after transgenic crops were first grown by 
smallholder farmers in the developing world, we now have a good deal of empirical 
evidence to draw upon. Several recent reviews of the literature have found that both the 
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performance and the impacts of GM crops have varied widely. A recent working paper 
from the ESRC STEPS Centre, for example, undermines the received wisdom that 
transgenic, insect-resistant Bt cotton has been ‘pro-poor’ and that it has produced 
benefits for the environment and human health. A number of recent papers by Melinda 
Smale and colleagues from the International Food Policy Research Institute and Terri 
Raney of the Food and Agriculture Organisation have drawn similar conclusions11. 
 
These detailed review papers make clear that a farmer’s ability to reap the potential 
benefits of GM technology depend on a wide range of technical, agronomic and 
institutional factors. For instance, the Bt trait needs to be available in suitably adapted 
cotton varieties that can perform in constrained environments. A good yield depends 
heavily on favourable soils and irrigation, which are the very things the poorest farmers 
typically lack. As the experiences of smallholder Bt cotton farmers in South Africa have 
vividly demonstrated, GM crop technology also needs to be backed by supportive 
investments in infrastructure and institutions if it is to benefit the poorest. 
 
Such work provides an important counter to the triumphalism of Clive James’ annual 
International Service for the Acquisition of Agri-biotech Applications (ISAAA) reports 
showing the spread of GM around the world12. While there is little doubt that GM crops 
have spread, it is also important to disaggregate the headline figures. Although GM 
crops were planted in 25 countries in 2008, only eight planted more than a million 
hectares. In fact, about 98m hectares out of a global GM crop area of 125m hectares 
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was grown in just three countries: the United States (62.5m hectares), Argentina (21m 
hectares) and Brazil (15m hectares). Moreover, the GM crops commercialised to date 
are primarily insect-resistant Bt varieties of maize and cotton and herbicide-tolerant 
varieties of soy, designed for and primarily used by larger scale, more commercial 
farmers. 
 
African agricultural policymakers do indeed have some difficult decisions to make. GM 
technology may well play a part in the mix of approaches required, but there are cons as 
well as pros to be considered. With only two basic traits currently available – insect 
resistance and herbicide tolerance – and big uncertainties on the horizon – such as 
market access and biosafety issues – it may be that a scientifically-informed, deliberate, 
‘wait-and-see’ stance makes a good deal of sense. 
 
Multiple pathways of technology change 
 
But what about the more distant future? One of the pivotal arguments in Starved for 
Science is that promising pipeline technologies and longer-term research are also being 
prevented. As an example, Paarlberg discusses the effort to develop drought-tolerant 
GM maize, a major Bill and Melinda Gates Foundation-supported programme of the 
African Agricultural Technology Foundation, which is working with a range of public and 
private research and development organisations.13 But this exciting initiative involves 
conventional breeding, genomics applications and marker-assisted selection as well as 
genetic modification. Yet Paarlberg zeroes in on the GM solution, making the (much 
disputed) case that this is where the necessary breakthroughs will happen.  
 
While there should be no argument against exploratory, blue skies research, the building 
of inflated expectations about pipeline technologies has major downsides. As has been 
seen in the field of medical biotechnology, generating unjustified expectations can distort 
innovation trajectories, diverting funds from other research foci and narrowing the focus 
of research to genetics, rather than wider environmental, behavioural and synergistic 
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dynamics.14 In the field of agricultural science, if we are not careful, a similar process will 
occur unless we retain a more balanced perspective on the different options available. 
 
Ron Herring of Cornell University argues that there is now an ‘empirical consensus’ on 
the value of GM crops in developing countries, that is opposed only by an ill-informed 
fringe.15 Nonetheless, the debate about pros, cons, aims, goals, benefits, costs, 
institutional and governance requirements continues – as it should. As with any new 
technology, our knowledge grows incrementally, and with varied results. Learning and 
experimentation is vital, and premature closure would be dangerous. 
  
A dogmatic and unscientific stance on GM crops – whether pro or anti – helps no one, 
and least of all African farmers. Paarlberg’s book has stirred up the debate again, but in 
ways that do not move it forward. A less combative, more evidence-based and balanced 
approach is needed, one that should foster a diversity of development pathways for 
agriculture16. All of these should be underpinned by high-quality scientific research and 
attuned to particular circumstances. As the World Bank’s World Development Report on 
Agriculture and the International Assessment of Agricultural Knowledge, Science and 
Technology for Development (IAASTD)17 both indicate, biotechnology options of many 
kinds will surely be part of the mix, but they will not be the only solution; and, for Africa, 
not necessarily the major one either. 
 
An edited version of this article appeared in the book reviews section of Nature on 
August 13 2009 
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